Bachem Holding AG's latest marketcap:
As of 10/14/2026, Bachem Holding AG's market capitalization has reached $7.36 B. According to our data, Bachem Holding AG is the 2762th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 7.36 B |
| Revenue (ttm) | 850.27 M |
| Net Income (ttm) | 178.76 M |
| Shares Out | 74.94 M |
| EPS (ttm) | 2.38 |
| Forward PE | 29.38 |
| Ex-Dividend Date | 05/04/2026 |
| Earnings Date | 03/04/2027 |
Bachem Holding AG's yearly market capitalization.
| Date | Market Cap(₣) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 10/14/2026 | ₣6.13 B | $7.36 B | 34.32% | 2762 |
| 12/30/2025 | ₣4.49 B | $5.58 B | 3.45% | 3134 |
| 12/30/2024 | ₣4.34 B | $4.78 B | -10.92% | 3093 |
| 12/29/2023 | ₣4.87 B | $5.79 B | -17.25% | 2557 |
| 12/30/2022 | ₣5.89 B | $6.37 B | -44.23% | 2193 |
| 12/30/2021 | ₣10.56 B | $11.57 B | 90.8% | 1615 |
| 12/30/2020 | ₣5.53 B | $0 | 155.61% | 2385 |
| 12/30/2019 | ₣2.16 B | $2.23 B | 40.35% | 4264 |
| 12/28/2018 | ₣1.54 B | $1.57 B | -26.08% | 4689 |
| 12/29/2017 | ₣2.09 B | $2.14 B | 70.71% | 4386 |
Company Profile
About Bachem Holding AG
Bachem Holding AG, along with its subsidiaries, delivers specialized products and services to pharmaceutical and biotechnology companies worldwide. The company focuses on research, clinical development, and commercial applications.
Core Offerings
- Peptide Active Pharmaceutical Ingredients (APIs): Development, production, and regulatory support for peptide and oligonucleotide new chemical entities (NCEs).
- Commercial NCEs & Generics: High-quality APIs for commercial use.
- Comprehensive Services: Includes project management, quality & regulatory support, analytical testing, GMP production, research-grade production, and vertical integration.
Company Background
Founded in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and has established itself as a leader in peptide-based pharmaceutical solutions.
Frequently Asked Questions
-
What is Bachem Holding AG's (SWX-BANB) current market cap?As of 10/14/2026, Bachem Holding AG (including the parent company, if applicable) has an estimated market capitalization of $7.36 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Bachem Holding AG (SWX-BANB) rank globally by market cap?Bachem Holding AG global market capitalization ranking is approximately 2762 as of 10/14/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.